The theme this year is “Transformative solutions for inclusive development: the role of innovation in fuelling an accessible and equitable world“.
The annual observance of the International Day of Persons with Disabilities (IDPD) on 3 December was proclaimed in 1992 by the United Nations General Assembly resolution 47/3. The observance of the Day aims to promote an understanding of disability issues and mobilize support for the dignity, rights and well-being of persons with disabilities.
The 2022 global observance to commemorate the International Day of Persons with Disabilities will be around the overarching theme of innovation and transformative solutions for inclusive development, covering in three different interactive dialogues the following thematic topics:
Innovation for disability inclusive development in employment (SDG8): this dialogue will discuss the linkages between employment, knowledge and skills required to access employment in an innovative, rapidly changing technological landscape to all and how assistive technologies can increase accessibility to employment and be mainstreamed in the workplace.
Innovation for disability inclusive development in reducing inequality (SDG10): this dialogue will discuss innovations, practical tools and good practices to reduce inequalities in both public and private sectors, which are disability inclusive and interested in promoting diversity in the workplace.
Innovation for disability inclusive development: sport as an exemplar case: a sector where all of these aspects coalesce; sport as a good practice example and a site of innovation, employment and equity.
This Article supports SDGs 3 and 10, examining the mortality risk for people aged 25-44 years with disability, and shows that the risk increases with different types and severities of disability and is particiularly associated with mental health problems and motor impairment
People with any disabilities accounted for a quarter of total deaths. People with disabilities had higher average ages and poor economic conditions. All disability types presented higher mortality rates and lower life expectancy. The major causes of death differed according to the type of disability.
Several studies of adult-onset multiple sclerosis (AOMS) patients have demonstrated that spinal cord volume loss is associated with disease progression and clinical disability; however, complementary studies of young patients with pediatric-onset multiple sclerosis (POMS) are lacking. In the context of SDG Goal 3, this retrospective study aimed to assess spinal cord volume in POMS patients compared with that in healthy controls.
This Article supports SDGs 3 and 10, assessing the effects of genomics, inheritance, and socioeconomic deprivation on neuropsychiatric risk in children with intellectual disabilities. The study shows that children with genomic variants and intellectual disability are at increased risk of neuropsychiatric difficulties.
In a 2019 national survey, 3.1% (95% confidence interval, 2.6%-3.5%) of practicing US physicians self-reported a disability, as defined by the Americans with Disabilities Act.2 Although the prevalence of reported disabilities in physicians is less than the general population, physicians may choose to not disclose their disabilities, especially hidden disabilities.
The aim of this study was to evaluate the effects of complete decongestive therapy (CDT) in patients with breast cancer-related lymphedema (BCRL), in regard to volume reduction, functional status and quality of life (QoL). In th context of SDG Goal 3, the study found that phase 1 CDT in a combined manner performed daily for 3 weeks, greatly reduces the volumes as well as improves the disability and QoL, especially when performed earlier.
This Viewpoint supports SDGs 3 and 10 by arguing that greater attention and emphasis should be placed on children with developmental disabilities in early childhood development strategies, which would necessitate funding and investment specifically for this patient population.
The COVID-19 pandemic is unprecedented. The pandemic not only induced a public health crisis, but has led to severe economic, social, and educational crises. Across economies and societies, the distributional consequences of the pandemic have been uneven. Among groups living in vulnerable conditions, the pandemic substantially magnified the inequality gaps, with possible negative implications for these individuals' long-term physical, socioeconomic, and mental wellbeing.
This Article supports SDG 3 by examining the cost-effectiveness of implementing at scale a set of evidence-based hearing care interventions recommended by WHO. The study finds that the implementation would offer a large return of investment, due to the substantial costs to countries posed by hearing impairment.
This Personal View supports SDGs 3 and 13, drawing attention to how the lived experiences of disability can deepen understanding of climate-resilient development, and how marginalisation increases vulnerability. The paper stresses the importance of solidarity in underpinning social choices.
An Article in support of SDG 3, estimating the global burden of tuberculosis, inclusive of post-tuberculosis morbidity and mortality, in view of the increasing evidence of long-term disability and elevated mortality risks in tuberculosis survivors.
An Article in support of SDG 3, showing that the age-adjusted prevalence of blindness has reduced over the past three decades, yet due to population growth, progress is not keeping pace with needs and vision impairment remains an urgent and increasingly important public health priority.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing different levels and magnitude of explanation for the various behavioral symptoms seen in individuals with ASD, collectively providing a comprehensive picture of this disorder.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the history and evolution of the definition and characterization of autism over the past several decades and the impact of it on how the disorder is perceived by autistic individuals, families, and professionals
A Multidisciplinary Approach to Diagnosis and Treatment
2022, Pages 322-337
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing a biopsychosocial approach that is key to optimal outcomes for patients with psychiatric illnesses.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining race, ethnicity, culture, national origin, color, gender, gender identity, sexual orientation, class, age, marital status, political belief, religion, geographic region, mental or physical disability, and historical or current experiences with the dominant culture to fully understand human behavior.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring the quality of online information on neurodevelopmental disorders, eating disorders, psychotic disorders, and mood and anxiety disorders.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the impact of the COVID-19 pandemic on the physical and mental health of the elderly.
From Fundamental Biology to Societal Impact
2023, Pages 725-744
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting early evidence on what it meant to be a frail older individual in the COVID-19 pandemic from the perspective of three different settings: community, hospitals, and nursing homes. Lessons learned provide opportunities to improve health outcomes, community and health services, and how we want to live as aging societies.
2022, Pages 73-94
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by focusing on the impacts of emergencies, disasters, and the COVID-19 pandemic on people with disabilities and chronic and mental health conditions
2022, Pages 55-72
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by looking at policies and frameworks for disaster risk reduction to ensure disability-inclusive disaster risk reduction practices across the world
The Vital Role of the Public Health Professional
2023, Pages 69-84
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring the impact of COVID-19 on employment, childcare, food security, and mental health.
The Vital Role of the Public Health Professional
2023, Pages 101-118
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the consequences of failing to adequately address long-standing social determinants and structural disparities related to the public's health
Towards Technological Advances and Service Innovations
2023, Pages 111-144
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting available evidence of the effects of acute COVID-19 illness on children and young people, the impact on at-risk groups, and access to mental health services and education during the pandemic, as well as discussing the implications and recommendations for research, practice, and policy.
Volume 5, 2022, Pages 39-67
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by outlining key aspects of disability studies and considers how this strongly emerging field is intersecting with scholarship and activism across many varieties of neurodivergence
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced inequalities by showing the effectiveness of neural mobilization on pain and disability in individuals with musculoskeletal disorders.
This book chapter advances SDG3 Good Health and Wellbeing and SDG10 Reducing Inequalities by focusing on the physically impaired who are unable to move about or carry out their day-to-day tasks independently in light of a new system with features that ensures a smooth and easy transition to a substantially improved quality of life.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring novel and advanced personalized medicine approaches to tailor depression treatments.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the evidence base for treatment of youth with depression, with a focus on management of treatment-resistant depression.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring herbal medicines role in depression to provide alternatives to current psychiatric drugs which may cause many induced side effects.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining Pharmacoepigenetics as an emerging field and the relation of epigenetic mechanisms to treatment response to inform treatment selection.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting the design, execution, and test results of the dyslexia health management system; and highlighting the high potential for worldwide deployment using blockchain technology.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting EEG and machine learning approaches to the classification of attention deficit and hyperactivity disorders for the improvement of specificity, reducing over diagnosis and under diagnoses, thereby avoiding undesirable consequences in adulthood.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by discussing how the inclusion of mental health providers with disabilities can improve the quality of patient care, and can add value to medical student and resident education.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the data on clinical and epidemiological predictors of antidepressant response, or predictors of treatment-resistant depression and discussing the possible prognostic value of clinical features, like severity, chronicity, subtypes of depression, comorbidities, history of trauma, and epidemiological features like gender, age, sociodemographic status.